Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac sodium 0.1% gel for sunburn pain
NCT00441051Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sunburn comparing Diclofenac sodium 0.1% Gel with Vehicle Gel (2 arms). Primary endpoint: Relief of provoked pain by Visual Analogue Scale at 24 hours. Started Nov 2006; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT00441051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441051.